Aberrant insulin signaling in Alzheimer's disease: current knowledge - Test2 - elhamkhani - TriplyDB

Aberrant insulin signaling in Alzheimer's disease: current knowledge

Aberrant insulin signaling in Alzheimer's disease: current knowledge

http://www.wikidata.org/entity/Q27024222

about

Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance.Early life exposure to obesogenic diets and learning and memory dysfunction.Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis.Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.The Associations among Insulin Resistance, Hyperglycemia, Physical Performance, Diabetes Mellitus, and Cognitive Function in Relatively Healthy Older Adults with Subtle Cognitive Dysfunction.Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease.Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Viral vectors for therapy of neurologic diseases.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Inhibitory Effect of Memantine on Streptozotocin-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Neurotrophic Factor Decline in Astrocytes.Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.Re-engineering therapeutic antibodies for Alzheimer's disease as blood-brain barrier penetrating bi-specific antibodies.Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology.Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.Olive polyphenols: new promising agents to combat aging-associated neurodegeneration.Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps.The neuroprotective effects of the anti-diabetic drug linagliptin against Aβ-induced neurotoxicity.The diabetic brain and cognition.Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer's Disease.Distinct Hippocampal Expression Profiles of Long Non-coding RNAs in an Alzheimer's Disease Model.The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain.Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease.Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome.Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.Impact of insulin signaling and proteasomal activity on physiological output of a neuronal circuit in aging Drosophila melanogaster.Identification of Insulin Receptor Splice Variant B in Neurons by in situ Detection in Human Brain Samples.iPSC-derived familial Alzheimer's PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling.Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease.Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury.Association of adiponectin with cognitive function precedes overt diabetes in the Brazilian Longitudinal Study of Adult Health: ELSA.Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer's Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus

P2860

Q26743384-991D4B9B-1691-4208-B75F-1ABF8CEBFE3D Q35866744-F5FE2E1C-BE68-4936-81BF-2E4F3B64CCF7 Q36550843-F869D992-BA6A-49E8-AB40-2397CC86625B Q36998610-D694DA5A-3D82-4DAB-B097-7DB629C0CCC0 Q37114306-888117FB-65E3-438E-B8C5-30F88CC688F4 Q37716724-DFB34448-E6AE-49BF-AFE6-A372F8719D27 Q38639674-2060661E-7745-4175-97DA-8A952D3C388A Q38659874-5A922397-07AF-4615-83CC-410689F65C6D Q38746238-10EB50AB-F1B7-4A6F-84ED-836B19B22711 Q38809233-EA0115DA-D579-4700-8E10-860480731E67 Q38812209-0ACEE2D8-04EB-4FED-8B26-BEF69772C7B4 Q38815881-52B319B5-1C3E-4F85-A6D7-60B23435F214 Q38826744-8C8A4913-8EF1-4ECD-A690-BF8E0AF4B74A Q38962792-FCA45DC0-5EE8-4753-95EB-B68DEA2F2D09 Q38974881-64B634DF-7730-4F07-A335-4A7588CB3A4A Q38980167-007A6769-D11D-4CED-B265-612634AA7473 Q38985937-F4FD975A-CAF6-43E3-8EFE-3DD8F4F097B8 Q39450295-BD106F9B-BC0F-4A00-A26B-829AFEC8531E Q39613110-C3E8A97E-6894-4932-954D-28ACA1C1B649 Q40098573-C22EA411-02E0-4150-B631-3536B4D02A4E Q41087317-868ABB1E-2AF0-46A1-BE0D-AFD106443023 Q42339277-D566E143-4B7E-486E-A2CC-C81F8F02D951 Q47111896-F842D8C9-F180-4DC9-B9E5-497260808012 Q47280369-A4A70745-21B6-43D8-91AA-F70EB2B48C52 Q47386735-918F26D1-2830-4F4F-8708-6705C724E9FB Q47774113-8146A29B-BB3D-4447-83AB-B364AE9C61CA Q48018264-4F98CE64-756C-4444-BE5A-4605033235DB Q48481506-9665C37C-E88C-46FE-A05A-4BB21EEFFDF8 Q48586051-D5495C80-6D2D-4FBC-95C6-88D715B3B1A7 Q50582002-0F02F666-5152-4883-BC5F-5AB4BD4A2A5F Q51533022-5E462CD5-8CDD-4589-9B9F-1A8427FC8E04 Q51759421-5D806D9F-80D0-4769-9524-37B2C8C2B296 Q51765382-A799C9DB-542D-46EC-9B17-5FFEEA6825AF Q55455350-980E53C9-2275-4AD2-A310-D68B1D68CC66 Q55493977-5154873C-2802-4E0C-A6CD-95492179CBAC Q55514148-9A9C1186-09E8-4B99-90F8-361123502AEA Q55693242-F0B32490-73A0-4615-A4B0-DA64A7963426 Q58609012-CAFDAE42-993B-4ACD-9A74-C7D0BA2B483D Q59137286-4458CB78-7854-4A4E-94C5-45A7849528BB

P2860

Aberrant insulin signaling in Alzheimer's disease: current knowledge

http://www.wikidata.org/entity/Q27024222

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@ast

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@en

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@nl

type

label

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@ast

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@en

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@nl

prefLabel

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@ast

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@en

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@nl

P1433

Q27024222-DF41474F-9DF1-48F7-B536-9AC2266565CB

P1476

Q27024222-208C1CA7-78D1-4F84-9BA3-62069958ECDF

P2093

Q27024222-846A626F-CDB9-4DAD-BF53-0C8A95BF553C

Q27024222-9A0B9BFC-414C-47B0-AFFC-629BC2D9D9D3

Q27024222-A81A198A-88A3-4CEB-B0BF-D98541D5C1F4

Q27024222-EBC36DC6-D4A0-4A17-B4CE-5F08F58B1BD3

P2860

Q27024222-00B6348A-B175-47DB-B8BA-3CD6CC287F41

Q27024222-0162B1FF-93D9-41BA-8698-A06701F707BB

Q27024222-05FF090D-7DB6-489A-AC1E-5998BB93095D

Q27024222-065C53A2-C754-4E67-AC3A-B08494067BFF

Q27024222-0810F4EB-332F-4274-B718-31017C27ADEF

Q27024222-08153911-850E-44D2-BABB-FADAED9B0AF0

Q27024222-0A3CD286-3960-464A-8E76-3FD856957033

Q27024222-0E896E26-00FD-437C-A199-D3F540E3A33C

Q27024222-10B1F9EE-3CAE-473A-8134-3DF8586FF19C

Q27024222-11641C74-F538-41C8-ADDF-82584A8C21B6

P304

Q27024222-01471882-0C04-4739-AD72-7DBFDFDA006A

P31

Q27024222-9E535802-5D9C-4E70-973B-E589B891CEAB

P3181

Q27024222-5A82B9E5-773F-4BE1-AAC7-8AF55C60E5CA

P356

Q27024222-3657986D-ACC8-4348-8092-7C31BEA68114

P407

Q27024222-F6D2A748-9B05-494B-B66F-582C21C33EEC

P478

Q27024222-165EE12E-2BE3-4E1A-B46F-67F72071793D

P50

Q27024222-16B52A14-A18A-4146-8BD6-21635DFB8F28

Q27024222-95ECC9ED-8BAF-40A5-8348-00F11504BB6F

Q27024222-9C41DF1C-F8EA-4DB2-B302-8D3F02856B98

Q27024222-E4542124-1B6D-4013-BF23-2F3BBB90CF8B

P577

Q27024222-2BBC0CD8-FC49-426E-A8A5-79AFF58A2665

P5875

Q27024222-CD2E5CDE-3CD9-4DE2-86F5-48CE41F71E01

P698

Q27024222-B8C22328-1C4A-496E-932C-978CFCD0563C

P921

Q27024222-2A6C7747-8414-4419-AEE1-2585E66C7857

Q27024222-3B7521F4-D444-4AC4-87D5-88AF585D99E7

P932

Q27024222-77C3A8B4-54D2-41B1-A1E8-2135CB23F1D6

P3181

P356

FNINS.2015.00204

P1433

Frontiers in Neuroscience

P1476

Aberrant insulin signaling in Alzheimer's disease: current knowledge

@en

P2093

Fabio Di Domenico

http://www.w3.org/2001/XMLSchema#string

Gaetano Serviddio

http://www.w3.org/2001/XMLSchema#string

Gaurav Bedse

http://www.w3.org/2001/XMLSchema#string

Tommaso Cassano

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin in central nervous system: more than just a peripheral hormone

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Alzheimer's Disease

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Insulin in the brain: there and back again

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

P304

204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1189723

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FNINS.2015.00204

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Di Domenico

Tommaso Cassano

Gaetano Serviddio

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279729041

http://www.w3.org/2001/XMLSchema#string

P698

26136647

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4468388

http://www.w3.org/2001/XMLSchema#string